BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2117030)

  • 1. Interaction of platelet-activating factor with interferon-gamma in the stimulation of interleukin-1 production by human monocytes.
    Barthelson R; Valone F
    J Allergy Clin Immunol; 1990 Aug; 86(2):193-201. PubMed ID: 2117030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin.
    Barthelson RA; Potter T; Valone FH
    Cell Immunol; 1990 Jan; 125(1):142-50. PubMed ID: 2293896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma.
    Valone FH; Epstein LB
    J Immunol; 1988 Dec; 141(11):3945-50. PubMed ID: 3141509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor stimulates expression of IL-1 beta mRNA in THP-1 cells.
    Barthelson RA; Valone FH
    Lipids; 1991 Mar; 26(3):257-60. PubMed ID: 1710753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes.
    Poubelle PE; Gingras D; Demers C; Dubois C; Harbour D; Grassi J; Rola-Pleszczynski M
    Immunology; 1991 Feb; 72(2):181-7. PubMed ID: 2016118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor.
    Ruis NM; Rose JK; Valone FH
    Lipids; 1991 Dec; 26(12):1060-4. PubMed ID: 1668105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming of human monocytes with PAF augments their production of tumor necrosis factor.
    Rola-Pleszczynski M
    J Lipid Mediat; 1990; 2 Suppl():S77-82. PubMed ID: 2133286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of platelet-activating factor by human monocytes stimulated by platelet-activating factor.
    Valone FH
    J Allergy Clin Immunol; 1991 Mar; 87(3):715-20. PubMed ID: 2005325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor potentiates interleukin-1/epidermal cell-derived thymocyte-activating factor release by guinea-pig keratinocytes stimulated with lipopolysaccharide.
    Pignol B; Lonchampt MO; Chabrier PE; Mencia-Huerta JM; Braquet P
    J Lipid Mediat; 1990; 2 Suppl():S83-91. PubMed ID: 2133287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of platelet-activating factor on peripheral blood monocytes: induction and priming for TNF secretion.
    Bonavida B; Mencia-Huerta JM; Braquet P
    J Lipid Mediat; 1990; 2 Suppl():S65-76. PubMed ID: 2133285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response.
    Al-Darmaki S; Knightshead K; Ishihara Y; Best A; Schenkein HA; Tew JG; Barbour SE
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):720-8. PubMed ID: 15242947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulatory functions of paf-acether. IV. Enhancement of IL-1 production by muramyl dipeptide-stimulated monocytes.
    Salem P; Deryckx S; Dulioust A; Vivier E; Denizot Y; Damais C; Dinarello CA; Thomas Y
    J Immunol; 1990 Feb; 144(4):1338-44. PubMed ID: 2105995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 activation of endothelium supports VLA-4 (CD49d/CD29)-mediated monocyte transendothelial migration to C5a, MIP-1 alpha, RANTES, and PAF but inhibits migration to MCP-1: a regulatory role for endothelium-derived MCP-1.
    Chuluyan HE; Schall TJ; Yoshimura T; Issekutz AC
    J Leukoc Biol; 1995 Jul; 58(1):71-9. PubMed ID: 7542307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in bronchial responsiveness, circulating leucocytes and ex vivo cytokine production by blood monocytes after PAF inhalation in allergic asthmatics.
    Louis R; Degroote D; Bury T; Corhay JL; Kayembe JM; Franchimont P; Radermecker MF
    Eur Respir J; 1995 Apr; 8(4):611-8. PubMed ID: 7664863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced human monocyte cytotoxicity by platelet-activating factor.
    Valone FH; Philip R; Debs RJ
    Immunology; 1988 Aug; 64(4):715-8. PubMed ID: 3169845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of the interleukin-8 gene by platelet-activating factor in human peripheral blood monocytes.
    Denault S; April MJ; Stanková J
    Immunology; 1997 Jun; 91(2):297-302. PubMed ID: 9227331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE).
    Bussolati B; Rollino C; Mariano F; Quarello F; Camussi G
    Clin Exp Immunol; 2000 Dec; 122(3):471-6. PubMed ID: 11122257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor and the production of human interferon-gamma.
    Yousefi S; Vaziri N; Carandang G; Villanueva JL; Khonsari S; Ocariz J; Cesario TC
    J Interferon Cytokine Res; 1997 Feb; 17(2):107-12. PubMed ID: 9058317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of tumour necrosis factor release by cytotoxic analogues of platelet-activating factor.
    Valone FH; Ruis NM
    Immunology; 1992 May; 76(1):24-9. PubMed ID: 1628897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term treatment with platelet-activating factor on IL-1 and IL-2 production by rat spleen cells.
    Pignol B; HĂ©nane S; Sorlin B; Rola-Pleszczynski M; Mencia-Huerta JM; Braquet P
    J Immunol; 1990 Aug; 145(3):980-4. PubMed ID: 2373865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.